Neuromuscular transmission is not impaired in axonal Guillain--Barré syndrome.

Kuwabara, Satoshi; Kokubun, N; Misawa, S; Kanai, K; Isose, S; Shibuya, K; Noto, Y; Mori, M et al. · J Neurol Neurosurg Psychiatry · 2011

case_series · Level IV

Where this comes from

Abstract

Previous studies have shown that anti-GQ1b antibodies induce massive neuromuscular blocking. If anti-GM1 and -GD1a antibodies have similar effects on the neuromuscular junction (NMJ) in human limb muscles, this may explain selective motor involvement in axonal Guillain--Barré syndrome (GBS). Axonal-stimulating single-fibre electromyography was performed in the extensor digitorum communis muscle of 23 patients with GBS, including 13 with the axonal form whose sera had a high titre of serum IgG anti-GM1 or -GD1a antibodies. All patients with axonal or demyelinating GBS showed normal or near-normal jitter, and no blocking. In both axonal and demyelinating GBS, neuromuscular transmission is not impaired. Our results failed to support the hypothesis that anti-GM1 or -GD1a antibody affects the NMJ. In GBS, impulse transmission is presumably impaired in the motor nerve terminal axons proximal to the NMJ.

Medical subject headings